The Croatian group PharmaS has landed in Spain with the purchase of a majority stake in the Spanish company MABO-FARMA.

MABO-FARMA has been advised by ANQUOR CORPORATE FINANCE in the process.

Founded in 1996 in Madrid, MABO-FARMA is one of the fastest growing companies in the Spanish generics retail market. With a portfolio of more than 200 references, one of MABO-FARMA’s greatest strengths is its excellence in the market, as it has a sales network of more than sixty people, geographically covering the whole of Spain.

With this acquisition, PharmaS will have reached 100 million euros in annual revenues with more than 150 employees in commercial operations covering the markets of South East Europe and Spain.

PharmaS was founded in 2008 in Zagreb, Croatia. It is present in most of the South East European markets and currently operates in seven countries. Its pharmaceutical business includes a broad portfolio of retail and hospital medicines as well as over-the-counter medicines. In addition, PharmaS is a leading company in the Adriatic region in the field of consumer health, having acquired the Dietpharm portfolio in 2019.